Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T23:04:10.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide NIH notice was added, announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T22:59:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-14T22:59:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision number was updated from v3.7.0 to v3.7.1, while the study record continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T23:05:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error instead of the study record content, with the error page shown in place of the usual ClinicalTrials.gov details.
    Difference
    19%
    Check dated 2026-09-23T23:02:51.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0 replacing v3.6.6, indicating a newer version of the page/document. This is a routine version update and does not modify the underlying study information.
    Difference
    0.1%
    Check dated 2026-09-16T22:23:35.000Z thumbnail image

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.